Vontobel Holding Ltd. Charles River Laboratories International, Inc. Transaction History

Vontobel Holding Ltd.

$27.3 Billion
Q4 2024

A detailed history of Vontobel Holding Ltd. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 1,817 shares of CRL stock, worth $319,646. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,817

Holding current value

$319,646

% of portfolio

0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	BUY	$178.58 - $220.69 $324,479 - $400,993	1,817 New	1,817 $335,000
Q1 2024 May 10, 2024	SELL	$203.52 - $273.43 $171,567 - $230,501	-843 Reduced 49.85%	848 $229,000
Q4 2023 Jun 03, 2024	SELL	$164.52 - $238.84 $15,464 - $22,450	-94 Reduced 9.53%	892 $210,000
Q4 2023 Jan 29, 2024	BUY	$164.52 - $238.84 $278,203 - $403,878	1,691 New	1,691 $399,000
Q2 2023 Jun 03, 2024	BUY	$183.71 - $210.25 $25,351 - $29,014	138 Added 16.27%	986 $207,000
Q2 2023 Jul 24, 2023	BUY	$183.71 - $210.25 $327,922 - $375,296	1,785 New	1,785 $375,000
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $660,121 - $837,484	3,349 New	3,349 $729,000
Q2 2022 Jul 27, 2022	SELL	$204.13 - $302.4 $504,201 - $746,928	-2,470 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $100,159 - $141,947	-392 Reduced 13.7%	2,470 $716,000
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $556,937 - $711,157	1,585 Added 124.12%	2,862 $1.08 Million
Q3 2021 Oct 29, 2021	BUY	$372.64 - $458.3 $139,740 - $171,862	375 Added 41.57%	1,277 $527,000
Q2 2021 Aug 06, 2021	BUY	$294.17 - $371.65 $265,341 - $335,228	902 New	902 $335,000

Others Institutions Holding CRL

# of Institutions

710

Shares Held

53.9M

Call Options Held

122K

Put Options Held

239K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.95B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Account

Vontobel Holding Ltd. Charles River Laboratories International, Inc. Transaction History